 |
|
Management of Endophthalmitis in the Post–Endophthalmitis Vitrectomy Study Era
Arch Ophthalmol. 2001;119:754-755.
|
|
| Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings. |
|
|
|
IN 1995, the Endophthalmitis Vitrectomy Study (EVS) Group1
published the results of a multicenter randomized clinical trial evaluating
the roles of pars plana vitrectomy and systemic antibiotics in the management
of postcataract extraction endophthalmitis. The article demonstrated that
immediate vitrectomy was not necessary in patients with visual acuity better
than light perception at the time of presentation, but that it was of significant
benefit for those with light perception only. In addition, the use of systemic
antibiotics did not enhance final visual acuity or media clarity. As a result,
the EVS has had a significant effect on the management of postcataract surgery
endophthalmitis. Most patients are now treated in the office with vitreous
tap and intravitreal antibiotic injection rather than pars plana vitrectomy,
and most can now be managed as outpatients and do not require hospitalization
with intravenous (IV) antibiotics.
In the current issue of the ARCHIVES, Doft et al . . . [Full Text of this Article] BLEB-ASSOCIATED ENDOPHTHALMITIS
DELAYED-ONSET ENDOPHTHALMITIS
TRAUMATIC ENDOPHTHALMITIS
ENDOGENOUS ENDOPHTHALMITIS
CONCLUSIONS
RELATED ARTICLE
Diabetes and Postoperative Endophthalmitis in the Endophthalmitis Vitrectomy Study
Bernard H. Doft, Stephen R. Wisniewski, Sheryl F. Kelsey, Shirley Groer Fitzgerald, and and the Endophthalmitis Vitrectomy Study Group
Arch Ophthalmol. 2001;119(5):650-656.
ABSTRACT
| FULL TEXT
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
|
The Post-Endophthalmitis Vitrectomy Study Era
Durand
Arch Ophthalmol 2002;120:233-234.
FULL TEXT
|
